Navigation Links
Actavis, Inc. to Present at the RBC Capital Markets Healthcare Conference
Date:2/12/2013

PARSIPPANY, N.J., Feb. 12, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT), a leading specialty pharmaceutical company, announced today that Paul Bisaro , Actavis' President and Chief Executive Officer, will provide an overview and update of the Company's business at the RBC Capital Markets Healthcare Conference on Tuesday, February 26, 2013 at 3:35pm ET at The New York Palace in New York, NY. The presentation will be webcast live and can be accessed on Actavis' Investor Relations Web site at http://ir.actavis.com.  The webcast can also be accessed at the following URL:

http://www.veracast.com/webcasts/rbc/healthcare2013/01114146.cfm

An archived version will be available approximately one hour after the live presentation ends and can be accessed at the same locations for 90 days.

About Actavis, Inc.Actavis, Inc. (NYSE: ACT) is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products.  The Company has global and U.S. headquarters in Parsippany, New Jersey, USA, and international headquarters in Zug, Switzerland. 

Actavis is the world's third-largest generics prescription drug manufacturer.  Operating as Actavis Pharma, the Company develops, manufactures and markets generic, branded generic, legacy brands and Over-the-Counter (OTC) products in more than 60 countries.  The Company is ranked in the top 3 in 12 global markets, the top 5 in 16 global markets, and in the top 10 in 33 global markets.   Actavis Pharma also develops and out-licens
'/>"/>

SOURCE Actavis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Watson Pharmaceuticals, Inc. is Now Actavis, Inc.
2. Actavis, Inc. to Host Fourth Quarter 2012 Earnings Conference Call and Webcast
3. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
4. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
5. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
6. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
7. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
8. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
9. Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
10. Hospira to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
11. Ultra Clean to Present at the Jefferies 2012 Global Technology, Media & Telcom Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)...  Humberto C. Antunes,  Galderma  worldwide CEO, will receive a ... of Drugs in Dermatology (JDD) at the upcoming ... is January 17-20, 2014, at the Omni Orlando Resort at ChampionsGate ... The ODAC is a distinguished event that delivers a ...
(Date:1/15/2014)... GARDENS, Fla. , Jan. 15, 2014  In an unprecedented effort ... and TB in ambulances and other transport vehicles, an advanced and ... by rescue personnel for the first time. In ... contact with these deadly pathogens, West Palm Beach ...
(Date:1/15/2014)... Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... Symphony® CGM System as a non-invasive, wireless continuous glucose ... , Executive Chairman and Interim CEO of Echo Therapeutics, ... Annual Equity Conference. Mr. Doman will ...
Breaking Medicine Technology:Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Superbugs No Longer Ride In Rescue Vehicles 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3
... Par Pharmaceutical Companies, Inc. (NYSE: PRX ) today ... increased the purchase price of its previously announced "Modified ... to purchase, for cash, up to $65,000,000 aggregate principal ... 2.875% Senior Subordinated Convertible Notes due 2010. , The ...
... DIEGO, Nov. 9, 2009 Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ... 30, 2009. , Arena reported a lower net loss allocable to ... or $0.38 per share, compared to a net loss allocable to ... or $0.76 per share, and a net loss allocable to common ...
Cached Medicine Technology:Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Note 2Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Note 3Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 2Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 3Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 4Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 5Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 7Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 8Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 9
(Date:4/17/2014)... Diego School of Medicine report that older women, plucky ... loss are more likely to be compassionate toward strangers ... in this month,s issue of the International Journal ... associated with better health and well-being as we age, ... the outcomes of individuals whose deficits in compassion put ...
(Date:4/17/2014)... team has created a new technology for modifying ... travel the body and selectively target cancer and ... devices that monitor and modify human physiology is ... no existing technology enabled bioengineers to build such ... respond in a customized fashion. , "The project ...
(Date:4/17/2014)... 2014) The cause of neuronal death in Parkinson,s ... that neurons may be mistaken for foreign invaders and ... the way autoimmune diseases like type I diabetes, celiac ... study was published April 16, 2014, in Nature ... controversial, idea in Parkinson,s disease; but if true, it ...
(Date:4/17/2014)... EcoHealth Alliance, a nonprofit organization that focuses on conservation ... today examining the current state of knowledge of the ... improved global surveillance strategies to combat the emergence of ... in West Africa that has claimed the lives of ... According to the World Health Organization (WHO), the ...
(Date:4/17/2014)... scientists and their partners have found that their proprietary ... transmission of multiple sexually transmitted infections (STIs) in both ... virus 2 (HSV-2), and human papillomavirus (HPV). The USAID-funded ... is effective against multiple strains of HIV, and has ... three viruses of at least eight hours prior to ...
Breaking Medicine News(10 mins):Health News:The ilk of human kindness 2Health News:Building 'smart' cell-based therapies 2Health News:Is Parkinson's an autoimmune disease? 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 3Health News:Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum 2
... , Statement of Esta Soler, President, Family Violence Prevention Fund , ... today in Los Angeles in the domestic violence case involving Chris ... like this. Despite what was apparently an extremely violent assault, ... remained a felony, and that Mr. Brown pleaded guilty, taking responsibility ...
... , LOS ANGELES, June 22 Mission Viejo general surgeon ... the newly-elected Chair of the Mutual Protection Trust (MPT) Board ... the Cooperative of American Physicians, Inc. (CAP). Dr. Cobo,s election ... J. Michael Wormley, MD, a Glendora family practitioner who presided ...
... isolated a potent inhibitor of tumor metastasis made by tumor ... treatment. Their findings were published in the online Early Edition ... during the week of June 22. Metastasisthe ... one of the leading causes of death from cancer, and ...
... Tarzana Medical Center on Friday became the first. hospital in the ... Vision RFD - in this case to aid a surgeon in ... a small stroke. , , Zahi E. Nassoura, a board-certified ... saw in the crystal-clear image provided by the Ziehm Vision, approved ...
... misdiagnosis as the likely cause of apparent uptick in melanoma ... released study in the June 2009 British Journal of Dermatology ... United Kingdom has concluded that the much-hyped melanoma "epidemic" is ... attributed the increase in melanoma diagnoses to heightened sensitivity and ...
... The Department of Veterans Affairs (VA) has initiated a large, ... health issues that may affect Operation Enduring Freedom/Operation Iraqi Freedom ... time period. VA,s "National Health Study for a New ... to OEF/OIF and 30,000 comparison Veterans who were not deployed. ...
Cached Medicine News:Health News:Domestic Violence Expert Comments on Chris Brown Plea Deal 2Health News:Dr. Juan Carlos Cobo Newly-Elected Chair of the Mutual Protection Trust Board of Trustees 2Health News:Potent metastasis inhibitor identified 2Health News:Providence Tarzana Surgeon First in U.S. to Use New State-of-the-Art Imaging Tool 2Health News:New Study Says Purported Melanoma Epidemic is Vastly Overstated 2Health News:VA Launches 10-Year Health Study of 60,000 New Veterans 2
Test for prostatic acid phosphatase...
... you could imagine the ultimate OR, how ... efficiency? Would its control systems be intuitive? ... to quickly adapt to different tasks and ... longer need to imagine this environment. It's ...
... is the world's first Windows ... measuring system. It allows data sharing ... is compatible with Microsoft Office 2000. ... see on the large, sharp 14.1-inch ...
... T-series is a new top-line range of ... and Atrial Fibrillation (AF). Because the T-series ... AF, the treatment of AF is taken ... technology the heart rhythm is monitored continuously ...
Medicine Products: